TARO PHARMACEUTICAL INDS LTD's ticker is TARO and the CUSIP is M8737E108. A total of 72 filers reported holding TARO PHARMACEUTICAL INDS LTD in Q2 2014. The put-call ratio across all filers is 0.38 and the average weighting 1.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $17,941 | +56.0% | 473 | 0.0% | 0.00% | – |
| Q1 2023 | $11,503 | -16.3% | 473 | 0.0% | 0.00% | – |
| Q4 2022 | $13,736 | -1.9% | 473 | 0.0% | 0.00% | – |
| Q3 2022 | $14,000 | -17.6% | 473 | 0.0% | 0.00% | – |
| Q2 2022 | $17,000 | -15.0% | 473 | 0.0% | 0.00% | – |
| Q1 2022 | $20,000 | -16.7% | 473 | 0.0% | 0.00% | – |
| Q4 2021 | $24,000 | -20.0% | 473 | 0.0% | 0.00% | – |
| Q3 2021 | $30,000 | -11.8% | 473 | 0.0% | 0.00% | – |
| Q2 2021 | $34,000 | -2.9% | 473 | 0.0% | 0.00% | – |
| Q1 2021 | $35,000 | 0.0% | 473 | 0.0% | 0.00% | – |
| Q4 2020 | $35,000 | +34.6% | 473 | 0.0% | 0.00% | – |
| Q3 2020 | $26,000 | -16.1% | 473 | 0.0% | 0.00% | – |
| Q2 2020 | $31,000 | +6.9% | 473 | 0.0% | 0.00% | – |
| Q1 2020 | $29,000 | – | 473 | +7783.3% | 0.00% | – |
| Q3 2018 | $0 | – | 6 | 0.0% | 0.00% | – |
| Q2 2018 | $0 | – | 6 | 0.0% | 0.00% | – |
| Q1 2018 | $0 | -100.0% | 6 | -97.0% | 0.00% | – |
| Q4 2017 | $21,000 | -4.5% | 203 | -1.9% | 0.00% | – |
| Q3 2017 | $22,000 | -33.3% | 207 | -29.6% | 0.00% | – |
| Q2 2017 | $33,000 | +13.8% | 294 | +14.0% | 0.00% | – |
| Q1 2017 | $29,000 | -6.5% | 258 | -10.4% | 0.00% | – |
| Q4 2016 | $31,000 | +40.9% | 288 | +44.0% | 0.00% | – |
| Q3 2016 | $22,000 | -26.7% | 200 | 0.0% | 0.00% | – |
| Q2 2016 | $30,000 | -70.0% | 200 | -71.4% | 0.00% | – |
| Q1 2016 | $100,000 | -6.5% | 700 | 0.0% | 0.00% | – |
| Q4 2015 | $107,000 | -16.4% | 700 | -22.2% | 0.00% | – |
| Q3 2015 | $128,000 | -0.8% | 900 | 0.0% | 0.00% | – |
| Q2 2015 | $129,000 | +22.9% | 900 | +21.6% | 0.00% | – |
| Q1 2015 | $105,000 | +425.0% | 740 | +428.6% | 0.00% | – |
| Q4 2014 | $20,000 | -9.1% | 140 | 0.0% | 0.00% | – |
| Q3 2014 | $22,000 | +10.0% | 140 | 0.0% | 0.00% | – |
| Q2 2014 | $20,000 | -98.4% | 140 | -98.8% | 0.00% | -100.0% |
| Q1 2014 | $1,284,000 | +6.6% | 11,568 | -5.0% | 0.00% | 0.0% |
| Q4 2013 | $1,204,000 | +6.6% | 12,177 | -18.0% | 0.00% | 0.0% |
| Q3 2013 | $1,129,000 | +52.2% | 14,851 | +12.0% | 0.00% | +100.0% |
| Q2 2013 | $742,000 | – | 13,265 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Claret Asset Management Corp | 86,474 | $6,524,000 | 1.34% |
| Analyst IMS Investment Management Services Ltd. | 28,438 | $2,143,000 | 0.64% |
| ALGERT GLOBAL LLC | 20,876 | $1,575,000 | 0.59% |
| Quantinno Capital Management LP | 9,351 | $706,000 | 0.48% |
| Crestline Management, LP | 37,000 | $2,792,000 | 0.45% |
| Empirical Finance, LLC | 9,561 | $721,000 | 0.20% |
| BRANDES INVESTMENT PARTNERS, LP | 55,065 | $5,469,000 | 0.14% |
| FORT, L.P. | 9,672 | $730,000 | 0.14% |
| CAXTON ASSOCIATES LP | 8,865 | $669,000 | 0.13% |
| ACADIAN ASSET MANAGEMENT LLC | 330,448 | $24,928,000 | 0.11% |